Title : Toxoplasmosis diagnosis and treatment: Current and futuristic trajectories
Abstract:
Toxoplasmosis is a global parasitic disease caused by the protozoan Toxoplasma gondii (T. gondii), with high infection rate that affect one third of human population, and results in sever implications in pregnant women, neonates and immunocompromised patients. Anti-parasitic treatments and schemes available against toxoplasmosis have barely evolved over the last two decades. The current anti-T. gondii therapeutics are not potent or effective in eradicating the tissue cysts produced by the parasite and have adverse side effects on body physiology specially in immunocompromised patients. This work aims at highlighting new trends in Toxoplasma gondii diagnosis by providing a comprehensive overview of the field, summarizing recent findings, and discussing the classic and new technological advancements in toxoplasma diagnosis and treatment. Novel current and perspective therapeutics utilizing trends in molecular, biophysics such as biosensors, epigenetics and artificial intelligence might provide solutions for diseases management and prevention. These insights will provide tools to identify research gaps and proffer novel planning options on the disease control.
What will audience learn from your presentation?
1.
Audience will gain comprehensive overview of the Toxoplasmosis field.
2.
They will learn about recent findings, and new technological advancements in toxoplasma diagnosis and treatment.
3.
They will be introduced to potential solutions for Toxoplasmosis management and prevention.
•
Explain how the audience will be able to use what they learn?
Audience will gain holistic and updated knowledge about Toxoplasmosis diagnosis and treatment, which might be utilized in their scientific/ academic fields and daily life. This information will also assist in providing solutions for this common global disease identification and potential treatment options for both layperson, policy maker or scientists.
•
How will this help the audience in their job?
This study will provide tools to identify potential promising therapeutics for Toxoplasmosis which might assist in increase public awareness, forming new collaborations, identify research gaps, improve concept design and provide novel planning options on the overall disease management.
